Skip to main content
. 2005 Fall;7(4):193–202.

Table 3.

Clinical Trials of Intravenously Administered Adenoviral Gene Therapy for Prostate Cancer

NIH No. Phase Indication Promoter Therapeutic
9910-345 I/II HR metastatic Rat probasin and PSA/PSE Replication (E1A and E1B)
0101-451 II HR metastatic Rat probasin and PSA/PSE Replication (E1A and E1B) + docetaxel

NIH, National Institutes of Health; HR, hormone-refractory; PSA/PSE, prostate-specific antigen promoter/enhancer. Data derived from http://www.gemcris.od.nih.gov.